Clinical trial

Drug Interaction Study Between Inhaled Beclomethasone and Protease Inhibitors in Healthy Volunteers

NCT00936793

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Darunavir Normalized identity: darunavirView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Ritonavir Normalized identity: ritonavirView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Beclomethasone Dipropionate HFA Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Drug Interaction Study Between Inhaled Beclomethasone and Protease Inhibitors in Healthy Volunteers

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-07-06

PhasePHASE1

Conditions

HIVunresolved

Asthmaverified · MONDO: asthma

Interventions

DarunavirDRUG · verified · RxNorm: darunavir

RitonavirDRUG · verified · RxNorm: ritonavir

Beclomethasone Dipropionate HFADRUG

Sponsors & collaborators

National Institutes of Health Clinical Center (CC)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00936793 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.